This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Structure-based Identification and Functional Characterization of SSH1 Inhibitors Investments < €500k United States of America 2016
Double-blocking Anti-crosslinking Strategy for AD Drug Development Investments < €500k United States of America 2016
Small molecule Parkin activators to treat Alzheimers Disease Investments < €500k United States of America 2016
A flavonoid gamma-secretase modulator (GSM) reduces beta-amyloid and tau pathologies in the AD mice Investments < €500k United States of America 2016
Preclinical assessment of an ABCA1 agonist as a novel therapeutic for AD Investments < €500k United States of America 2016
Activators of Nrf2 Translation in Alzheimers Disease Investments < €500k United States of America 2016
Targeting Neurovascular Dysfunction in AD Investments < €500k United States of America 2016
New piperazines effecting Abeta oligomer displacement from neuronal receptors Investments < €500k United States of America 2016
Screening for enhancers of sAPPalpha Investments < €500k United States of America 2016
Novel Aminoadamantane Nitrates for the Treatment of Neurological Diseases Investments < €500k United States of America 2016
